Amazon Discloses Up to $80B Loan Facility for AI Infrastructure as Free Cash Flow Turns Negative
The new borrowing line adds to a $220B capex year and a record negative trailing free cash flow.
Amazon (AMZN) disclosed in its third-quarter Form 10-Q a new loan facility of up to $80 billion to purchase technology infrastructure assets. Borrowings are available from the first quarter of 2027 through the third quarter of 2028, and each loan matures five years after it is drawn. The facility adds a new source of funding to a spending plan that already has trailing free cash flow at negative $42.4 billion, as Amazon builds AI data center capacity.
What the filing discloses
| Term | Detail |
|---|---|
| Size | Up to $80 billion |
| Purpose | Purchase of technology infrastructure assets |
| Availability | First quarter of 2027 through the third quarter of 2028 |
| Maturity | Each loan matures five years after drawdown |
| Disclosed in | Third-quarter 2026 Form 10-Q |
Because borrowing starts in 2027, the facility is a commitment for future spending, not money Amazon is using now. By our calculation, the availability window covers seven quarters, so an even drawdown would average about $11.4 billion a quarter. The earliest loans would mature in 2032 and the last in 2033 if drawn at the start and end of the window.
How it compares with Amazon's spending
| Measure | Figure | Context |
|---|---|---|
| Q3 capital spending | $77.3B | Mostly AI infrastructure for AWS |
| 2026 capex outlook | About $220B | Amazon expects 2027 to be higher |
| Trailing operating cash flow | $168.3B (+29%) | Twelve months to Sept. 30 |
| Trailing free cash flow | -$42.4B | From +$14.8B a year earlier |
| Loan facility | Up to $80B | About 36% of 2026 planned capex, by our calculation |
The facility equals roughly 47% of trailing operating cash flow and about 36% of the planned 2026 capital budget, by our calculation. It is large, but it is spread over seven quarters and sits beside much larger internal cash generation.
The quarter behind it
Amazon's third-quarter net sales rose 12% to $201.9 billion, and operating income reached $28.1 billion, a record 13.9% margin. AWS sales jumped 39% to $46.0 billion, the fastest growth in nearly five years, with operating income of $17.8 billion. Net income was $20.7 billion, or $1.89 per share, compared with $21.2 billion, or $1.95, a year earlier, when results included $9.5 billion of pre-tax gains on Anthropic investments. For the fourth quarter, Amazon guided net sales of $240 billion to $247 billion and operating income of $28.5 billion to $33.5 billion. Details are in Amazon's third-quarter results release.
Why it matters
Large technology companies are increasingly pairing record cash flow with borrowing to pay for AI buildouts. The facility gives Amazon committed financing for servers and related equipment during the years it expects spending to rise. Our earlier coverage details the quarter's capex and cash flow and Amazon's 2027 spending plans. For how the market has treated AI spending this week, see our Alphabet recap.
Sources: Amazon's Form 10-Q for the quarter ended Sept. 30, 2026 and third-quarter 2026 results release. Calculations labeled as ours use those figures. This is informational, not a recommendation to buy or sell.
Readers also read
Amazon Falls After Hours as $77B Quarterly Capex Sends Free Cash Flow to -$42B Despite AWS Surge
NewsAmazon Sees 2027 Capex Well Above $220B as Jassy Targets 40%-Plus AWS Growth Through 2028
RecapAlphabet Plunges 13% in Worst Day Ever, Erasing About $500B as AI Spending Turns Cash Flow Negative
MarketCatalyst is not a registered investment advisor and does not manage client assets. Content on this platform is provided for informational and educational purposes only. It is not investment advice, and MarketCatalyst is not a stock-picking or trade-alert service. Trading stocks and options involves risk, including the possible loss of principal. Consider your own goals, time horizon, and risk tolerance, and consult a qualified financial advisor before making any investment decision.